FRANKLIN LAKES, N.J.,
Aug. 21, 2019 /PRNewswire/ -- BD
(Becton, Dickinson and Company) (NYSE: BDX), a leading global
medical technology company, announced today that it will present at
the following upcoming investor healthcare conferences:
Wells Fargo Securities 2019 Healthcare Conference
September 4, 2019
11:25 a.m. EDT
Morgan Stanley 17th Annual Global Healthcare
Conference
September 11, 2019
9:20 a.m. EDT
Live webcasts of BD's presentations can be accessed on the BD
corporate website at www.bd.com/investors. They will be
available for replay for a period of seven days after each
conference.
About BD
BD is one of the largest global medical
technology companies in the world and is advancing the world of
health by improving medical discovery, diagnostics and the delivery
of care. The company supports the heroes on the frontlines of
health care by developing innovative technology, services and
solutions that help advance both clinical therapy for patients and
clinical process for health care providers. BD and its 65,000
employees have a passion and commitment to help enhance the safety
and efficiency of clinicians' care delivery process, enable
laboratory scientists to accurately detect disease and advance
researchers' capabilities to develop the next generation of
diagnostics and therapeutics. BD has a presence in virtually every
country and partners with organizations around the world to address
some of the most challenging global health issues. By working in
close collaboration with customers, BD can help enhance outcomes,
lower costs, increase efficiencies, improve safety and expand
access to health care. For more information on BD, please visit
bd.com.
Contact:
Kristen Cardillo, Communications -
201-847-5657
Monique Dolecki, Investor Relations
- 201-847-5378
View original
content:http://www.prnewswire.com/news-releases/bd-to-present-at-investor-healthcare-conferences-300905359.html
SOURCE BD (Becton, Dickinson and Company)